Key result
Urgent PCI and repeat angioplasty restore coronary flow after giant LMCA aneurysm and stent thrombosis.
Why the study?
Coronary artery aneurysms and ectasia are uncommon abnormalities associated with disturbed coronary flow and increased thrombosis risk, and their management is particularly challenging in patients with active malignancy due to substantially increased thrombotic and bleeding risks.
Case Report (n=1)
No
This case highlights the complex interplay between a giant left main coronary artery aneurysm and malignancy-associated hypercoagulability, illustrating the need for individualized, multidisciplinary balancing of severe thrombotic and bleeding risks.
Answers are grounded in this paper and cite their sources.
Case illustrates management challenges in malignancy-associated coronary aneurysms; leaves open evidence-based guidelines for revascularization and antithrombotic therapy.
Coronary artery aneurysms and ectasia are uncommon coronary abnormalities associated with disturbed coronary flow and an increased risk of thrombosis. Their management becomes particularly challenging in patients with active malignancy, in whom both thrombotic and bleeding risks are substantially increased. We report a 55-year-old male patient with metastatic pancreatic ductal adenocarcinoma admitted with NSTEMI. Coronary angiography revealed a giant LMCA aneurysm, significant LMCA/LAD disease, and chronic total occlusion of the RCA. Given the advanced malignancy and initial clinical stabilization, a multidisciplinary Heart Team selected a conservative strategy. Two months later, the patient was readmitted with chest pain and dyspnea and was diagnosed with segmental pulmonary embolism. Three hours later, an anterior STEMI developed due to thrombosis of the LMCA aneurysm and thrombotic LAD occlusion, requiring urgent LMCA/LAD PCI with two drug-eluting stents. On day 5, subacute LAD stent thrombosis required repeat PCI with balloon angioplasty. This case illustrates the challenges of balancing ischemic, thrombotic, and bleeding risks in patients with coronary artery aneurysms and active malignancy and highlights the importance of individualized multidisciplinary decision-making.
No takes yet. Share an insight, caveat, or question.
Południewski et al. (2026) conducted a case report in Giant left main coronary artery aneurysm with recurrent coronary thrombosis and metastatic pancreatic ductal adenocarcinoma (n=1). Initial conservative management with DAPT followed by urgent LMCA/LAD PCI with two drug-eluting stents, repeat balloon angioplasty, and triple antithrombotic therapy was evaluated on Clinical stabilization and coronary flow restoration following aneurysm thrombosis and subacute stent thrombosis. Urgent LMCA/LAD PCI with two DES and repeat angioplasty restored coronary flow after thrombosis of a 14x28 mm LMCA aneurysm and day-5 subacute stent thrombosis in a 55-year-old with pancreatic cancer.
Synapse has enriched 10 related papers. Consider them for comparative context: